Literature DB >> 34255587

Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series.

Manisha Agarwal1, Mani Sachdeva1, Surendra Pal2, Harita Shah3, Madhu Kumar R4, Alay Banker3.   

Abstract

PURPOSE: To report six patients with endogenous endophthalmitis as a complication of COVID-19 infection.
METHODS: A multicentric retrospective database review of patients with a diagnosis of endogenous endophthalmitis and a history of COVID-19 infection.
RESULTS: Four of six patients were diabetics. All presented after an average duration of 40 days (Range 17-90 days) of COVID-19 infection. Two of six patients had bilateral involvement. Five of six patients had received intravenous corticosteroid for COVID-19. Two of six vitreous samples showed fungi (Candida and Bipolaris species), two showed bacteria (Staphylococcus species) and two samples were culture negative. Control of infection with good visual outcome in four out of eight eyes.
CONCLUSIONS: COVID-19 patients with a history of hospitalization and prolonged use of systemic corticosteroids and comorbidities, for example, diabetes mellitus have a high risk of endogenous endophthalmitis. A high index of clinical suspicion with timely intervention can salvage many eyes.

Entities:  

Keywords:  COVID-19; Endogenous endophthalmitis; corticosteroids; immunocompromised

Mesh:

Year:  2021        PMID: 34255587     DOI: 10.1080/09273948.2021.1945111

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

1.  Endogenous endophthalmitis due to methicillin-resistant Staphylococcus aureus bacteremia in a patient with COVID-19.

Authors:  Tim Brotherton; Eugene Nwankwo; Debapria Das; Adam Fritz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-10-26

2.  Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID-19: A case report.

Authors:  Mohammad Javad Zibaeenezhad; Alireza Moaref; Firoozeh Abtahi; Mohsen Moghadami; Mohammad Karim Johari; Ali Ardekani; Mohammad Keshavarz
Journal:  Clin Case Rep       Date:  2022-05-12

3.  Management of presumed candida endophthalmitis during the COVID-19 pandemic: Case report and review of the literature.

Authors:  Federica Fossataro; Francesco Martines; Piergiorgio Neri; Pia Allegri; Alfredo Pece
Journal:  Eur J Ophthalmol       Date:  2022-04-04       Impact factor: 2.597

4.  Commentary: Fungal endophthalmitis - Newer insights into the diagnosis and management.

Authors:  Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

5.  Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report.

Authors:  Sinsucha Boontantrapiwat; Duangnate Rojanaporn; Weerawan Chokthaweesak; Naris Kitnarong
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-16

6.  Endogenous fungal endophthalmitis in COVID-19 patients: An unexplored possibility.

Authors:  Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.